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EXPLANATORY  MEMORANDUM 
The  modified  proposal  for  a  Council  Decision  for  the  research  programme 
In  biomedicine  and  health  takes  account  of  the  amendments  from  the 
European  Parliament  which  are  either  "horizontal",  I.e.  common  to  all 
programme  proposals,  or  specific  to this  programme. 
Horizontal amendrents 
The  Commission's  attitude with  regard  to these  amendments  Is  the  same  as 
for  the  other  programmes.  As  far  as  comltology  Is  concerned,  the 
Commission  stl I I  wishes  for  a  Type  I I 1-a  Committee,  as  It  had  proposed, 
whl lethe Parliament  wants  this changed  Into a  Type  I  Committee. 
Specific amendments 
The  chief  characteristics  of  the  modifications  arising  from  these 
amendments  are  as  follows: 
Improvement  of  the  present  at I  on  of  the· techn I  ca I  content  (Annex  I) 
substantially  In  accord  with  the guidance  from  CREST; 
addition  of  a  fourth  area  of  research  In  biomedical  ethics,  which 
goes  along  with  the  tendency  to  attach  more  Importance  to  the 
ethical  and  social  consequences of  research; 
modification of  the  Indicative distribution of  the  budget  : 
a  reasonable  reduction  In  the  amount  foreseen  for  human  genome 
ana I  ys Is  (on  account  of  the  recent  commencement  of  the  programme 
which  forms  part  of  the  second  framework  programme)  and  an  increase 
of  resources  for  the  Area  "Major  hea I th  prob I  ems  and  dIseases  of 
great  socio-economic  Impact",  In  particular  for  the  AIDS  sector. - 4-
Modified  Proposal  for  a 
COUNCIL  DECISION 
adopting  a  specific  research  and  technological  development  programme  in 
the  field of  Biomedicine  and  Health  (1990-1994). 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES, 
Having  regard  to  the  Treaty  establishing  the  European  Economic 
Community,  and  in  particular Article  130q  §2  thereof,-
Having  regard  to  the  proposal  from  the  Commlsslon1, 
In  cooperation  with  the  European  Paritament2, 
Having  regard  to  the opinion of  the  Economic  and  Social  Commlttee3, 
Whereas,  by  Its  Decision  90/221/Euratom,  EEc4,  the  Council  adopted  a 
third  framework  programme  ·tor  Community  activities  In  the  field  of 
research  and  technological  development  (1990  to  1994),  specifying  Inter 
at Ia  the  activities to be  pursued  for  contributing· to  the  development  of 
the  European  potential  for  understanding  and  exploiting  the  properties 
and  structures  of  living  matter;  whereas  this  Decision  should  be  taken 
"  in  the  light  of .the  grounds set  out  In  the  preamble  to  that  Decision; 
" 
Whereas  Article  130k  of  the  Treaty  stipulates  that  the  framework 
programme  shall  be  Implemented  through  specific  programmes  developed 
within each  activity; 
Whereas  an  estimate  should  be  made  of  the  amount  of  Community  financial 
resources  needed  to  carry  out  this  specific  programme;  whereas  the 
definitive  amounts  wl  I I  be  fixed  by  the  budgetary authority  In  I lne  with 
the  financial  perspectives  covering  the  period  1988-1992  Included  In  the 
Interinstitutional  Agreement  of  29  June  19885  and  with  any  future 
financial  perspectives  covering  the  period  1993-1994; 
1  OJ  n·  c 
2  OJ  n·  c 
3  OJ  w  c 
4  OJ  N"  L  117.  8. 5.1990,  p.28 
5  OJ  w  L  185,  15.7. 1988.  p.33 _,_ 
Whereas  fundamental  research  must  be  soeclflcal ly  encouraged  Community-
wide  In  each  of  the  strategic  research  sectors  of  the  frameworK 
programme; 
Whereas.  In  addition  to  the  specific  programme  on  hyman  capital  and 
mobl'lltv. ·training  of  researchers  In  each  of  the  strategic  research 
sectors of  the  frameworK  programme  must  be  ensured; 
Whereas  the  social  and  hyman  Impact  of  the  programme  must  be  assessed 
by  an  Independent  pane I  and  techno logy  and  rIsk  assessment  be 
undertaken.  particularly  In  the  field of  bloethlcs: 
Whereas,  pursuant  to  ·Article  4  and  Annex  I  of  Decision  90/221/Euratom, 
EEC,  the  funds  est !mated  as  necessary  for  the  whole  of  the  frameworK 
programme  Include  an  amount  of  57  million  ecus  for  the  centralised 
dissemination  and  exploitation  of  results,  to  be  divided  up  In 
proportion  to  the  amount  envisaged  for  each  activity;  whereas  In  view  of 
the  Importance  of  thld  specific  programme  within  the  "Life  Sciences  and 
Technologies"  action  the  estimate  of  the  financial  resources  needed  by 
this programme  Is  to be  reduced  by  1.33 million ecus,  which  amount  Is  to 
be  allocated  to  the  said centralised activities,  In  order  to comply  with 
the  second  sent~nce of  Article  130p  §2  of  the  Treaty; 
Whereas  this programme  must  be  implemented  by  the  Commission;  whereas  to 
to  help  accomplIsh  this,· the  Member  States  are  bound,  pursuant  to 
Article  5  of  the  Treaty,  to  facilitate  the  achievement  of  Its  tasks 
where  necessary,  notably within  a  committee; 
Whereas  this  programme  must  be  Implemented  essentially  by  the  selection 
of  research  and  deve I  opment  projects  to  enable  them  to  benet It  from 
Community  participation;  whereas  the  Commission  should  encourage  the 
submission  of  such  projects  by  the  usual  means  of  pub! lshlng  calls  for 
proposa Is  In  the  OffIcI a I  Journa I;  whereas  an  except lona I  procedure 
shou I  d  ·a I  so  be  devIsed  so  as  to  come  Into  effect  between  ca I Is  for 
proposals  to  maintain  a  degree  of  flexibility  enabling  the  Commission, 
In  the  face  of  the  continuous·  evolution  and  gradual  acceleration  of 
techn·o log I  ca I  progress,  a !so  to  take  Into  cons I  de rat !on  spontaneous 
proposals consistent  with  the objectives of  the  programme; ..  6  -
Whereas  suoport  for  the  International  competitiveness  of  European 
Industry.  through  Community  research  and  technological  deyelopment 
programmes.  Is  linked  with  the  Community's  external  relations  policy 
based  on  the  principle of  "the global  eayl I lbrlym of opportunities".  and 
that  It  Is  also  In  the  light  of  this  policy  that  participation  of 
European  companies  owned  by  citizens of  non-Community  coyntrles  myst  be 
considered;  '; 
Whereas  'the  projects  .to  .be .carried  out .under  .the  programme  must  be 
selected  with  special  attention  to  the  principle  of .economl~ and  social 
cohesion  In  the  Community,  to  the  transnational  nature  of  the  proJects 
and  to  the  support  to  be  given  to  smal I  and  medium-sized enterprises; 
Whereas  It  Is  only  In  the  light  of  experience  gathered  In  the  course  o~ 
development· of  this  programme  that  the  Commission  wl  I I  be  able  to 
propose  and  the  Council  ·to  adopt  supplementary.  programmes  by  having 
recourse  to  the  means  provided  for  In  Articles  130  I,  130m or  1~0 o  of 
the  Treaty,  If  they  contribute  to  the  achievement  of  the·  programme's 
objec~lves,-ln accordance  with  the option made  aval !able by  Article 2(2) 
of  the  Decision 90/221/Euratom,  EEC; 
Whereas,  In  accordance  with  Article  130g  of  the Treaty,  the Community  's 
activities aimed  at  strengthening  the scientific and  technological  basis 
of  European  Industry  and  encouraging  It  to  become  more  competitive 
Include  promoting  cooperation  on  research  and  technological  development 
with  third  countries  and  international  organisations;  whereas  such 
cooperation may  prove  particularly  beneflcl~l  to  the  development  of  thli 
programme; 
Whereas  It  Is  necessary,  as  Annex  II  to  Decision  90/221/Euratom,  EEC, 
provides,  to  contribute  to  lmpro~ing  the  efficacy  of  medical  and  health 
research  and  development  In  the  Member  States,  In  particular  by  better 
coordination  of  the  Member  States'  research  a·nd  development  activities 
and  application  of  the  results  through  Community  cooperation  and  a 
pool lng  of  resources; 
Whereas  the Scientific and  Technical  Research  Committee  (CREST)  has  been 
consu I ted, - 7-
HAS  ADOPTED  THIS  DECISION 
Article  1 
1.  A  specific  research  and  technological  development  progrmme  for  the 
European  Economic  Community  In  the  field of  biomedicine  and  health, 
as  defIned  In  Annex  I,  Is  hereby  adopted  for  ~  per lod  from  the 
date  of  publication  of  this  Decision  In  the  Official  Journ·al  to 
31  December  1994. 
Article 2 
1.  The  Community  funds  estimated  as  necessary  for  the execution  of  the 
programme  under  this Decision  amount  to·133 million ecus.  From  these 
funds,  an  amount  of  1.33  million  ecus  Is  drawn  for  the  centralised 
action  of  disseml.natlon  and  exploitation  of  results.·  The·  amount 
thus  reduced  to  131.67  ml  I I lon  ecus  Includes staff costs  which  may 
not  exceed  4%.  An  Indicative  breakdown  of  expenditure  Is  set  out  In 
Annex  I I. 
2.  Should  the  Council  take  a  decision  .In  ·Implementation  of 
Article  1(4)  of  Decision 90/221/Euratom,  EEC,  this Declslon·shal 1.  be 
adapted  to  take  account  of  the  above-mentioned  decision. 
3.  The  budgetary  authority shal I  decide on  the  appropriations  aval !able 
for  each  financial  year. 
Article 3 
Rules  for  the  Implementation of  the  programme  are set out  In  Annex  Ill. 
Article 4 
The  rate  of  the  Community  financial  contribution  shal I  be  laid  down  In 
accordance  to  Annex  IV  to Decision 90/221/Euratom,  EEC 1 . 
2. 
- B-
Article 5 
' 
Our lng  1992  the  Commission  shall  review  the  programme  and  !address  a 
report  on  the  results of  the  review  to  the  Council  and  the
1  European 
Pari lament,  together  with  proposals  for  any  necessary  changes. 
I 
At  the  end  of  the  programme,  the  Commission  shal I  assess  t~e results 
obtained.  It shall  address  a  report  thereon  to  the  Counclll  and  the 
European  Parliament. 
3.  The  reports  shall  be  drawn  up  having  regard  to  the  obJectives  set 
out  In  Annex  I  to  this  Decision  and  In  accordance  wlth  Ar~lcle 2(4) 
of  Decision  90/221/Euratom,  EEC.  These  reoorts  shal I  assess  the 
coherence  of  the  programme's  measurable  Implementation  wl~h  the  six 
rna lor  concerns  set  out  In  Annex  I I  of  Coyne!!  i  peclslon 
90/221/Euratom,  eecs. 
Article 6 
' 
1.  The  Commission  shall  be  responsible  for  the  executlo.n  of  the 
programme.  It shall  be  assisted by  a  committee,  herelnafte~ referred 
to  as  "the  Committee",  composed  of  representatives  of  the  Member 
States  ~nd chaired  by  a  representative of  the  Commission. 
2.  The  contracts  concluded  by  the  Commission  shall  govern  the  r lghts 
and  obligations  of  each  party,  Including  the  procedures  for 
dlssemlnat lng,  protect log  and  exploit log  the  research  results,  In 
accordance  with  the  arrangements  adopted  pursuant  to  the  second 
paragraph  of  Article  130k  of  the  Treaty  and.  where  appropriate, 
orocedyres  for  training  and  eyalyatlon. 
3.  A  work  programme  shal I  be  drawn  up  at  the  start of  the  programme  and 
shall  be  regularly  revised.  It  shall  set  out  the  detailed objectives 
and  types  of  projects  to  be  undertaken,  and  the  financial 
' 
arrangements  to  be  made  for  them.  The  Commission  shal I  make  calls 
for  proposals  for  projects  on  the  basis of  the  work  programmes. 
6  O.J.  n  l  117,  8.5.1990 -9-
Article 7 
1.  In  the  cases  envisaged  In  Art lcle  8(1),  the  Commission 
representative shall  submit  to  the Committee  a  draft  of  the  measures 
to  be  taken.  The  Committee  shall  deliver  Its  opinion  on  the  draft 
within  a  time-limit  which  the  chairman  may  set  according  to  the 
urgency  of  the  matter.  The  opinion  shall  be  delivered  by  qualified 
majority  as  provided  for  In  Article  148(2}  of  the  Treaty  for  the 
adoption  of  decisions  which  the  Council  Is  called  upon  to make  on  a 
proposal  from  the  Commission.  When  voting  takes  place  In  the 
Committee,  the  votes  of  the  representatives  of  the  Member  States 
shal I  be  weighted  as  specified  In  the  above-mentioned  Article.  The 
chairman  shall  not  take  part  In  the  voting. 
2.  The  Commission  shal I  adopt  the  measures  envisaged  where  they  are  In 
accordance  with  the Committee's opfnlon. 
3.  If  the  measures  envisaged are  not  In  accordance  with  the  Committee's 
opinion,  or  if  no  opinion  Is  del lvered,  the  Commission  shal I 
forthwith  submit  to  the  Council  a  proposal  relating  to  measures  to 
be  taken.  The·Councll  shall  act  by  a  Qual lfled majority. 
4.  If  the  Council  has  not  acted  within  one  month  of  submission  of  the 
proposal,  the  proposed measures  shall  be  adopted  by  the  Commission. 
Article 8 
1.  The  procedure  laid  down  In  Article 7  shall  apply  to  : 
preparation  and  updating  of  the  work  programmes  referred  to  In 
Article 6(3); 
evaluation  of  the  projects,  referred  to  In  point  2  of  Annex  Ill, 
as  well  as  the  estimated  amount  of  the  Community's  financial 
contribution,  when  these  projects  are  submitted  through  the 
ordinary  procedure  referred  to  In  point  4  of  Annex  Ill  and  the 
above-mentioned  amount  Is  more  than  5  mill ton  ecus; 
evaluation  of  all  projects  submitted  through  the  exceptional 
procedure  referred  to  In  point  4  of  Annex  Ill,  as  well  as  the 
estimated  amount  of  the  Community's  financial  contribution; 
measures  for  evaluating  the.  programme. - 10-
2.  The  Commission  may  consult  the  Committee  on  any  matter  falling 
within  the  scope  or  the  programme. 
3.  The  Commission  shal I  Inform  the  Committee  with  regard  to 
the  progress of  the  programme; 
planned  cal Is  for  proposals,  referred  to  In  Article 6(3); 
projects,  referred  to  In  point  2  of  Annex  Ill,  submitted  through 
the  ordinary  procedure,  for  which  the  Community  contribution  Is 
less  than  5  ml  I I ion  ecus,  and  the  results of  their  evaluation; 
accompanying  measures,  referred  to  In  point  2 of  Annex  I I I; 
concerted  actions,  referred  to  In  point  2 of  Annex  I I I. 
Article 9 
In  Implementing  this  programme,  supplementary  programmes  within  the 
meaning  of  Article  1301,  participation  within  the  meaning  of 
Article  130m  and  Joint  undertakings  or  any  other  structures  within  the 
meaning  of Article  130o  of  the Treaty  may  also  be  decided on  as  the  need 
arises. 
Article  10 
.Where  cooperation  with  third  countries  and  International  organisations 
aiming  at  achieving  the  objectives  of  this  programme  requires  legal 
undertakings  between  the  Community-and  the  third  parties  concerned,  the 
Commission  sha II  be  author I  sed  to  negot late,  In  accordance  wl th 
Art lcle  130n  of  the  Treaty,  International  agreements  laying  down  the 
terms  of  such  cooperation. 
Priority  wt  I I  be  qiyen  to  cooperation  with  EFTA  countries  and  European 
countries  not  members  of  the  European  Community.  In  accordance.  where 
appropriate,  with  the  guidelines  drawn  uo  between  the  Councl I  and  the 
European  Pari lament  during  the  concl I latlon  orocedure  on  the  third 
framework  programme. - 11-
The  negotiations  for  such  International  agreements  may  only  be  Initiated 
with  third  countries  who  are  already  signatories  of  an  agreement  with 
the  Community  which  explicitlY  cites  research  and  technological 
development  or  scientific  progress  as  one  of  the  oblectlyes  of 
cooperation. 
Decisions  on  the  conclusion  of  such  International  agreements  shall  be 
adopted  In  accordance  with  the  procedure  referred  to  In  Article  130q(2) 
of  the  Treaty. 
Article  11 
This  Decision  Is  addressed  to  the Member  States. 
Done  at  Brussels,  ...........  . 
For  the  Counc II, 
The  President - 12-
Annex  I 
SCIENTIFIC  AND  TEa-tNICAL  OBJECTIVES AND  CONTENT 
This  specific  programme  fully  reflects  the  approach  embodied  In  the 
Third  Framework  Programme  In  terms  of  the scientific and  technical  goals 
and  the  underlying  alms  which  It  pursues. 
Paragraph  4C  of  Annex  II  of  the  Framework  Programme  forms  an  Integral 
part  of  the  present  specific programme. 
Close  coordination  wl  I I  be  maintained  with  other  relevant  research 
programmes,  including  "Biotechnology",  "Life  Sciences  and  Technologies 
for  Developing  Countries",  "Telematlcs  Systems- Health  Care",  "Medical 
Research"  under  the  European  Coa I  and  Stee I  CommunIty  Treaty,  and ~ 
the  "Europe  against  Cancer"  programme. 
The  principle  of  subsidiarity  will  be  applied  to  the  maximum~ 
Harmonisation of  approaches  and  methodologies  used  In  different  national 
programmes  w  I I I  be  encouraged.  The  proJects  wIthIn  the  programme  w  I I I 
have  a  European  dimension  based  on  research  networks.  Their  main 
criteria  will  be  aual!ty  and  addltlonalltv.  Strengthening  of  networks. 
cart lcularly  by  the  establ lshment  of  "European  Laboratories  Without 
Walls".  wl  I I  arm  at  the  development  of  specific  and  competitive  sublect 
areas.  Mobi llty  of  research  workers  between  participating  laboratories 
wl  I I  be  encouraged.  including  for  short  periods of  time. 
Harmonised  methods, ·specific  to  the  relevant  protocols,  wl  I I  ensure  that 
the  data  resulting  from  the  projects  carried  out  throughout  the 
Community  can  be  analysed  and  exploited  anywhere  In  the  Community. 
Coordination  with  national  actlyltles  wl  I I  ensure  effective  use  of 
resources. 
The  fundamental  role  of  basic  research  In  underpinning  the  work  of  the 
programme  Is  recognised.  Prenormatlve  research  will  be  developed 
whenever  needed  for  the  completion  of  the  Internal  Market,  In  respect 
of  serving patients'  needs. 
The  foi rowing  presents  an  analytical  description  of  the  content  of  the 
programme,  based  on  and  taking  account  of  the  above  elements. - 13-
Area  1  Development  of  coordinated  research  on  prevention.  care  and 
hea I th .sv_s.te.ms 
This  area  covers  the  harmonisation  of  methodologies  and  protocols  In 
epidemiological.  biological.  cl In leal  and  technological  research. 
The  key  targets wl  I I  be  : 
l 
Precompetltlve  drug  testing  and  research  Into  the  monitoring  and 
surveil lance  of  dryg  orescrlblng  practices.  patient  compliance  and  the 
Incidence  of  adverse  dryg  reactions  wl  I I  be  carried  oyt.  based  on 
clinical  and  epidemiological  data  collected  through  coordinated 
networks.  and  with  a  vtew  to  an  !moroyed  harmonisation  of  norms. 
parameters  and  gy!del lnes. 
Risk  factors  relating  to  occypat!onal  health.  Including  dangerous 
substances and  biological  agents.  will  be  studied with  the  aim  of  their 
Identification.  and  of  risk  prevention  and  of  early  detection  of 
disease.  Among  the  syb!ect  fields  wll I  be  Information  methods  for 
workers  about  safety  and  cost-effective management  of screening  systems. 
Research  related  to  the  genetic  screening  of  workers  for  apparent 
oredlsposltlons  to  occypatlonal  diseases  and  workplace  hazards.  and 
which  Imp! !es  those  workers'  participation.  wl  I I  not  be  conduCted 
without  their  consent. 
Enhancement  and  app! !cation  of  biomedical  technology  to  medical  and 
health  care  wl  I I  be  directed  towards  the development  of  coherent  systems 
and  procedures  for  diagnosis.  therapy.  prevention.  care  and 
rehabilitation.  Coordination of  basic  research  <model  I log)  In  biomedical 
technology  will  be  aimed  at  fundamental  Insight  Into  falling  hyman 
functions  and  on  the  characteristics  of  blomaterlals.  Applied 
technological  research  will  be  aimed  at  artificial  systems  to  restore 
fall log  human  functions  and  alleviate  handicaps  as  completely  as 
DOSS lb !e. 
lastly.  sypport  myst  be  given  In  these  different  fields  to  my!tlcentre 
studies  between  countries  to  facilitate  the  granting  of  patents. 
epidemiological  studies  and  authorisations  for  the  marketing  of  new 
medicinal  products. 
Harmon!sat ion  of  protocols  and  approaches  In  health  services  will  be 
emphasised.  particularly  with  Europe  1992  In  y!ew.  Research  will  be 
carried  oyt  Into  the  financing  of  health  care.  the  management  of  the 
health  care  workforce.  and  health  care  systems.  The  methodology  of 
research  Into  prevention.  therapy  and  rehab! I !tattoo  wl  I I  also  be 
studied. - 1~-
Area  2  Maler  health  oroblems  and  diseases of great  socio-economic  lmoact 
Major  health  problems  and  economically  and  socially  significant  disease 
groupings  wl  I I  be  considered,  In  particular  the  following 
AIDS 
The  research  will  take  Into  account  the  activities already  developed  by 
the Community  and  wl  I I  be  spread over  five main  sectors  : 
disease  prevention- concentrating  on  specific  epidemiological 
projects,  studies of  primary  and  secondary  prevention,  assessment 
of  preventive strategies,  behavioural  research  and  forecasting, 
fundamental  research  concentrating  on  AIDS  viruses,  host 
response,  pathogenesis  and  experimental  models; 
clinical  research  - concentrating  on  clinical  trials,  clinical 
manifestations,  support  of  clinical  centres  and  national 
coordination, 
the  development  of  a  European  Vaccine  against  AIDS  (EVA)  will  be 
actively  pursued.  A  centralised  facility  will  work  In 
col laboratlon  with  Industrial  and  academic  laboratories  to 
produce  antigens,  sera,  eel Is  and  other  materials, 
testing  methods  of  Antiviral  Drugs  In  AIDS  Management  (ADAM)  wl  I I 
be  developed.  Primary  screening  capacity  will  be  Increased  by 
Introducing  additional  primary  screening methods. 
In  this  specific  area  col laboratlon  with  other  European  Community 
act Ions.  including  the  specific  programme  on  "Life  Sciences  and 
Technologies  for  Developing  Countries".  will  receive  particular 
attention. CANCER 
Epidemiology  and  fundamental  research  on  genomic  and  phenotypic  changes 
In  cancer  cells  <Invasion  and  metastasis)  and  lnunune  surveillance  will 
be  extended.  Particular  attention  wl II  be  cald  to  research  Into 
oncogenes  and  antloncogenes.  Priority  support  activities  will  Include 
the  Improvement  of  European  tumour  cell  and  tissue  bank  resources,  and 
the  development  of  the  scientific basis  for  common  guidelines  for  anti-
cancer  drug  screening. 
Research  wl  1  I  concentrate  on  Improved  methodologies  Involving  differing 
combinations  of  surgery,  radiotherapy,  chemotherapy  and  Immunotherapy, 
and  their  subsequent  harmonisation  with  associated  local  and  general 
approaches. 
Research  w  I I I  a 1  so  be  carrIed  out  on  the  I Inks  between  env I  ronmenta I 
factors  and  the  Incidence  of  cancer.  with  the  aim  of  developing 
preventive  approaches.  In  coordination  with  the  research  programme  on 
the  environment. 
In  conJunction  with  the  "Europe  against  Cancer"  programme.  particular 
attention wll I  be  paid  to  research  In  the  area of  paediatric oncology. 
CARDIOVASCULAR  DISEASE 
The  var lous  forms  of  heart  and  circulatory  disease  will  be  studied, 
focusIng  on  research  where  coherent  broad I  y-based  c I In I  ca I  .a.ru1 
epidemiological  surveys  are  most  useful;  this  will  Include  correlation 
between  genetic  factors,  lifestyle,  nutrition,  and  the  Incidence  and 
development  of  cardiovascular  disturbances,  the  effects of  prophylactic 
and  therapeutic  measures,  the  development  of  new  regimens  for  treatment 
Including  non-Invasive  methods  of  diagnosis,  and  the  testing of  drugs. 
MENTAL  ILLNESS  AND  NEUROLOGICAL  DISEASE 
Multidisciplinary  approaches  to  the  study  of  aetlologlcal  factors  and 
pr ed I  spos I  nq  cond I t Ions  w  I I I  be  deve I  oped  In  a  range  of  psychosoc I  a I 
environments.  The  aim  of  such  studies  will  be  to  Improve  understanding 
of  the  causes of  mental  Illness and  also  the  evolution  from  pathology  to 
dlsab! I ltv  and  social  disadvantage.  and  to  deyelop  new  methods  of 
prevention  and  care. - 18-
A global  approach  to  the  study of  central  neryoys  system malfunctioning 
common  to  pathological·  and  physiopathological  Condit Ions  will  be 
pyrsyed.  to  lm'0rove  understandlngof  aetlooathogenlc mechanisms. 
Soeclflc  studies  wl I I  be  carried  oyt  In  the  areas  of· enzvmology. 
neuroendocrinology  and  genetics. 
particular  attention  will  also  be  paid  to  the  part  played  by  mental 
processes  In  the· development  of  diseases  sych  as  cancer.  AIDS  or 
cardiovascular  disorders. 
AGEING,  AND  AGE-RELATED  HEALTH  PROBLEMS  AND  HANDICAPS 
Research  on  perinatal  Illnesses  <Including  the  study  of  the  social  and 
economic  Impact  of  prenatal  diagnosis>  and  paediatric  Illnesses  and  on 
the  effectiveness  of  prophylactic  and  therape~tlc  measures  wl-1  I  be 
carried out. 
The  avera! I  target  for  research  In  the  field of  ageing  will  be  directed 
towards  prevention  of  and  coping  with  dependency.  A  concerted  approach 
to  the  study  of  ageing  will  be  pursued  In  order  to  Identify  essential 
elements  In  the  ,maintenance  of  the  Quality  of  life  In  the  aged,  In 
preventing  or  delaying  the  functional· decline of  the  Individual,  and  In 
reducing  costs  to  society.  Emohasls  will  be  olaced  on  longltud.lnal 
studies  on  ageing  In  different  cultural  settings.  and  on  specific 
pathologies  relating  to  ageing  such  as  senile  dementia.  osteoporosis. 
ahd  disorders  of  the  Immune  system.  Special  attention  wl  II  be  given  to 
the  effects  of  the  env 1  ronment  on  hea I th,  espec I  a I I  y  on  peop I  e  In  the 
more  vulnerable  age  groups;  this  will  be  pursued  In  close  liaison  with 
research  on  environmental  protection.· 
Studies  wl  I I  be  carried out  on  methods  of  Improving  organ  transplants. .  1/ 
Area  3  Human  Genome  Analysis 
This  research  will  be  developed  towards  the  completion  and  the 
Integration  of  the  genetic  and  physical  maps.  In  addition,  the  study  of 
the  genetic  basis  for  biological  functions  will  be  pursued,  as  well  as 
the  setting-up of  a  coordinating  mechanism  to  sequence  a  portion of  the 
genome  of  major  biological  Interest  (e.g.  the  port !on  coding  for  the 
Human  Lymphocyte  Antigen  system) .. 
Emphasis  wll I  be  placed  on  medical  applications  which  contribute  to  the 
well-being  of  patients  In  coordination  with  other  elements  of  the 
research  programme  In  biomedicine  and  health.  to  ensure  that  the 
advances  In  the  understand 1  ng  of  genetIcs  are  ysed  to  enhance  human 
health  In  particular,  on  understanding  the  genetic  component  of 
multifactorial  conditions  such  as Alzheimer's disease,  and  on  developing 
methods  Intended  to  Improve  therapies. 
Links  wl  I I  be  maintained  with  appropriate  International  organisations or 
forums  (e.g.  HUGO,  the  Human  Genome  Organisation),  as  well  as  with 
research  actions  In  non-member  states  using  similar  or  complementary 
approaches.  The  Community  programme  Is  characterised  by  Its emphasis  on 
gene  mapping  and  on  the  use  of  Information  resulting  from  the  analysis 
of  other  spec les'  genomes.  It  Is  therefore  Important  that  the  research 
programme  ·In  biomedicine  and  health  should  !Ink  closely  with  relevant 
activities elsewhere  In  the  framework  programme. 
Particular  attention  and  caution  will  be  given  to  the  ethical,  social 
and  legal  aspects  of  this  work,  especially  to  those  which  may  be  I Inked 
to  poss I  b I  e  mIsuses  of  research  fIndIngs.  No  research  mod I fy I  ng,  or 
seeking  to  modify,  the  genetic  constitution  of  human  beings  by 
alteration of  germ  eel Is  or  of  any  stage of  embryo  development  which  may 
make  these  alterations  hereditary  wl  I I  be  carried  out  under  this 
programme. 
However.  the  results  of  this  research  must  enable  the  genetic  data -of 
the  donors  required  for  transplants  to  be  establ lshed  at  any  time. - 11!-
Area  4  Research  on  Biomedical  ethics 
Studies  wl  I I  deal  with 
- the  compilation  of  current  legislation  on  bloethlcs  and  current 
prolects; 
- the organisation of  meetings of experts  In  the  field of  bloethiCs 
with  a  ylew  to drawing  up  CommunitY  positions; 
- the  evaluation of  the  social  Impact  of  the  programme.  as  well  as 
any  technological  risks which  may  be  associated with  It; 
- the  assessment  of  the  bloethlcal  aspects of  the  various  research 
programmes  In  the  framework  programme  of  Community  actly!tles and 
research. 
preparatory studies wl  I I  be  undertaken with  a  ylew  to  the setting up 
of  a  European  ethical  observatory  In  conlunctlon  with  the  European 
Institutions  and  organisations. - 19-
Annex  I I 
INPICAIIVE  BBEAKPOWN  OF  EXPENP!IURES 
In%.  for  the  period  1990-1994 
Area  Development  of  coordinated  research  on 
prevention.  care and  health systems 
Area  2  MaJor  health  problems  and  diseases 
of  great  socio-economic  Impact. 
with  AIDS  receiving  50%  of  the  sum  for  Area  2 
Area  3  Human  Genome  Analysis 
Area  4  Research  on  Biomedical  ethics  : 
5%  of  the  total  for  Areas  1.  2  and  3. 
20  - 25 
55  - 60 
20  - 25 
The  breakdown  between  different  areas  does  not  exclude  the  posslbi I lty 
that  proJects  could  cover  several  areas. 
1.  An  amount  eauivaient  to  10%  of  the  total  shal I  be  used  for  orolects 
encouraging  fundamental  research.  which  should  be  clearly 
Identified. 
2.  An  amount  equivalent  to 5%  of  the  total  shal I  be  devoted  to prolects 
encouraging  the  training bf  researchers  In  the field  covered  by  this 
specific programme. Annex  I I I 
- 20-
RULES  FOB  I  MPL EMENTI NG  THE  PROGRAMME  ANP  ACT IV I  I  I  ES 
FOR  DISSEMINATION  ANP  EXPLOITATION  OF  THE  RESULTS 
1.  The  Commission  shall  Implement  the  progranvne  on  the  basis  of  the 
scientific and  technical  content  described  In  Annex  I. 
2.  The  rules  for  Implementing  the  programme,  referred  to  In  Article  3, 
comprise  research  and  technological  development  projects, 
accompanying  measures  and  concerted actions. 
The  projects  shal 1  be  the  subject  of  shared-cost  research  and 
technological  development  contracts. 
The  accompanying  measures  cons.lst  of  applying  the  means  to  ensure 
proper  technical  execution,  management  and  evaluation  of  the 
programme,  as  well  as  adequate  dissemination  and  accessibility  of 
the  results,  and  coordination,  training and  consciousness-raising of 
the  participants  In  the  programme; 
The  concerted  actions  are  those  defined  In  Article  92  of  the 
Financial  Regulation. 
3.  The  participants  In  the  projects  must  be  natural  or  legal  persons 
established  In  the  Community,  such  as  universities,  research 
organisations  and  Industrial  firms,  Including  smal I  and  medium-sized 
enterprises,  or  associations  thereof,  In  particular  European 
Economic  Interest  Groupings  (EEIGs). 
Natural  or  legal  persons  establ lshed  In  countries  which  have 
concluded  cooperation  agreements  on  scientific·  and  technical 
research  with  the  Community  may,  on  the  principle of  mutual  benefit, 
participate  In  the  projects  undertaken  In  the  framework  of  this 
programme.  Such  contracting  parties will  not  benefit  from  Community 
financing  under  the  framework  programme.  They  wl  I I  contribute  to  the 
general  administrative costs. 
4.  The  choice  of  projects  shal I  be  carried  out  according  to  the 
following  order  of  priority,  the  first  method  being  the  rule,  the 
second  the  exception. - 21-
The  participants  In  the  projects  shal 1  be  selected  on  the  basis  of 
the  ordinary  procedure  of  cal Is  for  proposals  referred  to  In 
Article 6(4)  and  published  In  the  Official  Journal  of  the  European 
Communities. 
Where  other  criteria of  scientific excellence  are satisfied.  and  In 
accordance  with  the  guide! toes  agreed  between  Councl I  and  the 
Eurocean  par! lament.  In  the  case of  a  number  of  protect  proposals of 
equal  scientific value.  preference  shal I  be  glyen  : 
(I)  to  protect  proposals  whose  Implementation  lnyo!yes  proJect 
participants  In  less-developed  regions  and/or  regions  In 
Industrial  decline  as  defined  by  Articles  8  and  9  of  Council 
Regulation  EEC  N'  2052/88. 
(I I)  to  pro lect  propos  a Is  1  nyo I  y I  ng  sma II  and  medIum-s I zed 
entreprlses or  an  association of  such entreprlses. 
The  Commission  shall  determine  In  each  case  whether  the  management 
of  the  crogramme.  or  parts  thereof.  can  be  undertaken  by 
organisations  or  Institutions  outside  the  Commission.  without 
delegation of  Its decision-taking  powers. 
The  Commission  may  also.  accept  proposals,  according  to  an 
exceptional  procedure  and  under  the  conditions mentioned  below,  when 
they  make  a  particularly  promising  and  significant  contrlbutlon.as 
regards  the  originality  of  the  theme  proposed,  the  novelty  of  the 
scientific  and  technical  approach  and  the  methodology  of  execution, 
also  taking  Into account  the  particular  nature of  the  proposers. 
A  favour ab I  e  techn I  ca 1  eva I  ua t I  on  of  such  proposa Is  sha I I  not  by 
Itself  be  a  sufficient  ~ustlflcatlon  for  accepting  a  project;  this 
exceptional  procedure  may  only  apply  after  verification  that  the 
nature of  the  project,  as  defined  above,  does  not  justify the  use of 
the  normal  procedure  for  cal Is  for  proposals. 
The  exceptional  procedure  shall  come  Into  effect  after  the  first 
cal I  for  proposals  and  must  be  completed  before  the  ordinary 
procedure  In  such  a  way  that  the  available  amount  for  the 
Community's  financial  participation  In  projects  retained  by  the -22-
ordinary  procedure  can  be  determined  precisely.  The  closing date  for 
the  exceptional  procedure  shall  be  pub! !shed  each  year  In  the 
Official  Jqurllal  of  the  European  Communities. 
When  It  submits  the  preliminary  draft  b4dget  the  Commission  shall 
Inform  the  budgetary  authority  whether  the  aporoprlatlons  approved 
In  the  budget  of  the  previous  year  haye  also  financed  orolects 
retained  by  the  exceptional  procedure  and  the  amounts  allocated. 
Shou I  d  these  pro lects  coyer  sever  a I  orogrammes.  It  sha I I  state  the 
tvpe of  committee  which  assisted  !t. 
··  ... 
The  amount  of  the.  financial  participation  of  the  Community  for all 
the  projects  ret  a !ned  by  the  except !ona I. procedure  will  be  decIded 
each  year,  In  relation  to  the  projects  selected  according  to 
particularly strict. criteria of  excellence.  In  any  case  this  amount 
may  not  exceed  10%;  It  may  be  revised  each  year  In  the  light  of 
experience. 
The  Commission  shall  draw  up  a  vade-mecum  setting out  all  the  rules 
applicable  to  this  exceptional  procedure  ln  order  to  guarantee  full 
transparency. 
5.  The  projects must  Involve at  least  two  mutually  Independent  partners 
establ !shed  to  different  Member  States. 
6.  The  Commission  may  encourage  the  participants  to  form  a  European 
Economic  Interest  Grouping  (EE!G)  or  make  other  arrangements  for 
carrying  out  projects,  such  as  those  on  a  large  scale,  permitting 
decentral ised  management  adapted  to  the specific  requirements of  the 
project. 
7.  The  knowledge  acquired  during  the  course  of  the  projects  shall  be 
disseminated  on  the  one  hand  within  the  specific  programme  and  on 
the  other  hand  by  means  of  a  centralised  activity,  pursuant  to  the 
deciBion.referred  to  In  th~ third paragraph  of  Article  4  In  Decision 
.90/221/Euratom, .EEC. EN 
PRICE 
ISS~ 0254-1475 
COM(90) 676 final 
DOCUMENT-S 
15 
C~atalogue number: CB-C0-90-678-EN-C 
ISBN 92-77-67935-2 
l  - 30 pages: 3.50 ECU  per additional 10 pages: 1.2.S ECU 
OWce for Official Publications of the European Communities 
L-2985 Luxembourg 
., 
'I 
' II. 
I 